Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - ACCOUNTS PAYABLE
Accounts Payable ALNY - Alnylam Pharmaceuticals, Inc.
55.5 M
LAST VALUE
-13.04%
2 YEAR CAGR
-1.44%
5 YEAR CAGR
25.14%
10 YEAR CAGR